Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

NDS Head of Department makes a splash in many international news sites with the published results of his 10 year ProtecT Study. A trial of 1,643 men with small prostate cancers resulted in the same 99% survival rate after a decade for those who had had surgery, radiotherapy or simply monitored the tumour.

Prof Freddie Hamdy © Academy of Medical Sciences
Professor Freddie Hamdy

Read more in the publication in the New England Journal of Medicine: http://www.nejm.org/doi/full/10.1056/NEJMoa1606220#t=article

BBC: http://www.bbc.co.uk/news/health-37362572

Guardian: https://www.theguardian.com/society/2016/sep/14/monitoring-prostate-cancer-effective-treatment

Telegraph: http://www.telegraph.co.uk/news/2016/09/14/prostate-cancer-survival-rates-equally-high-if-you-monitor-disea/

Financial Times: https://www.ft.com/content/34f1a9c8-78f7-11e6-a0c6-39e2633162d5

The Times: http://www.thetimes.co.uk/article/most-prostate-cancer-sufferers-can-avoid-pain-of-early-surgery-6rp8q8ml8

The Washington Post: https://www.washingtonpost.com/news/to-your-health/wp/2016/09/14/almost-all-men-with-early-prostate-cancer-survive-10-years-regardless-of-treatment/

New York Times online: http://www.nytimes.com/aponline/2016/09/14/health/ap-eu-med-prostate-cancer.html?_r=1 

NBC News online: http://www.nbcnews.com/health/health-news/all-prostate-cancer-treatments-about-equally-effective-study-finds-n648471

CBC online (Canada): http://www.cbc.ca/news/health/prostate-cancer-1.3762576 

Daily Telegraph Australia online: http://www.dailytelegraph.com.au/news/breaking-news/treat-or-monitor-early-prostate-cancer/news-story/9cff4fc64f9e56a5053a3103949a0ecf 

Channel NewsAsia online: http://www.channelnewsasia.com/news/world/prostate-cancer-options-show-little-difference-in-survival/3128170.html 

Further coverage

Call to watch and wait on male cancer

The Daily Mirror, 07/11/2017, p.15, Rosie Taylor

Too many men are diagnosed with prostate cancer when it will not harm them, Oxford University’s Professor Freddie Hamdy said. He argued that in many cases they should not be told they have it. He said that out of 500 diagnoses, 75% avoided treatment for three years and 44% for more than 10. He said patients “driven by anxiety” to tackle the cancer often opted for needless surgery or radiotherapy, leading to urinary and bowel problems and sexual dysfunction.

Ignore cancer call

The Sun, 07/11/2017, p.24, Unattributed

https://www.thesun.co.uk/news/4856964/men-prostrate-cancer-stress-oxford-professor/

Why not treating prostate cancer ‘is best for most men’

Daily Mail, 07/11/2017, p.27, Sophie Borland & Rosie Taylor

http://www.dailymail.co.uk/news/article-5056043/Prostate-cancer-patients-better-not-diagnosed.html

‘Better off undiagnosed’

Daily Mail (Ireland), 07/11/2017, p.12, Katie O’Neill

Similar stories

ASPI honours ProtecT Trial for pioneering research demonstrating the safety of active surveillance

The ProtecT Trial has been named the 2024 recipient of the Active Surveillance Patients International (ASPI) Special Award for game-changing research in the development of the Active Surveillance approach to managing low-risk prostate cancer.